Cargando…

Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease

OBJECTIVE: Inflammatory bowel disease (IBD) is a chronic, autoimmune, gastrointestinal disorder. Canada has one of the highest prevalence and incidence rates of IBD in the world. Diagnosis is challenging due to the similarity of symptoms to functional gastrointestinal disorders. Faecalcalprotectin (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wei, Wong, Chiew Hsia, Chavannes, Mallory, Mohammadi, Tima, Rosenfeld, Greg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500206/ https://www.ncbi.nlm.nih.gov/pubmed/30987989 http://dx.doi.org/10.1136/bmjopen-2018-027043

Ejemplares similares

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England
por: Murphy, Jacqueline, et al.
Publicado: (2017)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
por: Komraus, Marzena, et al.
Publicado: (2012)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
por: Khalil, Ahmed F., et al.
Publicado: (2020)

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
por: Bromke, Mariusz A., et al.
Publicado: (2021)

FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease
por: Rosenfeld, Greg, et al.
Publicado: (2016)

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015)

Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the THIN data
por: Freeman, Karoline, et al.
Publicado: (2021)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy
por: Freeman, Karoline, et al.
Publicado: (2019)

Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic
por: Jere, Mwansa, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care data
por: Lohan, Christoph, et al.
Publicado: (2023)

Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020)

Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021)

Cost of breast cancer diagnosis and treatment in India: a scoping review protocol
por: Barathe, Priyanka Chandrakant, et al.
Publicado: (2022)

Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application
por: Husain, Muhammad Jami, et al.
Publicado: (2022)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
por: Azouz, Hanan Galal, et al.
Publicado: (2021)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
por: Ellakany, Walid Ismail, et al.
Publicado: (2022)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients
por: Soare, Iulia, et al.
Publicado: (2021)

In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models
por: Shine, Brian, et al.
Publicado: (2019)

Healthcare resource utilisation pattern and costs associated with herpes simplex virus diagnosis and management: a systematic review
por: Lee, Shaun Wen Huey, et al.
Publicado: (2022)

Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approach
por: Mistry, Hema, et al.
Publicado: (2012)

Cost-effectiveness of rapid laboratory-based mass-spectrometry diagnosis of bloodstream infection: evidence from the RAPIDO randomised controlled trial
por: Dixon, Padraig, et al.
Publicado: (2021)

Healthcare resource utilisation and costs associated with a heart failure diagnosis: a retrospective, population-based cohort study in Sweden
por: Boman, Kurt, et al.
Publicado: (2021)

The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study
por: Fordham, Richard, et al.
Publicado: (2012)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website: cost-effectiveness analysis
por: Hunter, Rachael, et al.
Publicado: (2017)

Cost-effectiveness of a patient-centred approach to managing multimorbidity in primary care: a pragmatic cluster randomised controlled trial
por: Thorn, Joanna, et al.
Publicado: (2020)

Faecal calprotectin and rectal histological inflammatory markers in cystic fibrosis: a single-centre study
por: Roda, Juliana, et al.
Publicado: (2022)

A systematic review of the cost and cost-effectiveness of electronic discharge communications
por: Sevick, Laura K, et al.
Publicado: (2017)

Diagnostic accuracy of faecal calprotectin in patients with active perianal fistulas
por: Stevens, Toer W, et al.
Publicado: (2019)

Fecal Calprotectin in Combination With Standard Blood Tests in the Diagnosis of Inflammatory Bowel Disease in Children
por: Ho, Shaun S. C., et al.
Publicado: (2021)

The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis
por: Ross, Fiona A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k1ga351jijpjg3dieuks3ivt9p